Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity

• Published in: Journal of neuroinflammation Vol. 15; no. 1; p. 1
• Main Authors: Wilkaniec, Anna, Gąssowska-Dobrowolska, Magdalena, Strawski, Marcin, Adamczyk, Agata, Czapski, Grzegorz A
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.01.2018; BioMed Central; BMC
• Subjects: Alzheimer’s disease; Amyloid beta; Analysis; Care and treatment; Cdk5; Cytokines; Development and progression; Gene expression; Genetic aspects; Nervous system diseases; Neuroinflammation; Physiological aspects; Protein kinases; Poland; Neuroinflammation; Amyloid beta; Alzheimer’s disease; Cdk5; Cytokines; Gene expression
• ISSN: 1742-2094; 1742-2094
• DOI: 10.1186/s12974-017-1027-y

Cyclin-dependent kinase 5 (Cdk5) belongs to the family of proline-directed serine/threonine kinases and plays a critical role in neuronal differentiation, migration, synaptogenesis, plasticity, neurotransmission and apoptosis. The deregulation of Cdk5 activity was observed in post mortem analysis of brain tissue of Alzheimer's disease (AD) patients, suggesting the involvement of Cdk5 in the pathomechanism of this neurodegenerative disease. However, our recent study demonstrated the important function of Cdk5 in regulating inflammatory reaction. Since the role of Cdk5 in regulation of inflammatory signalling in AD is unknown, we investigated the involvement of Cdk5 in neuroinflammation induced by single intracerebroventricular (icv) injection of amyloid beta protein (Aβ) oligomers in mouse. The brain tissue was analysed up to 35 days post injection. Roscovitine (intraperitoneal administration) was used as a potent Cdk5 inhibitor. The experiments were also performed on human neuroblastoma SH-SY5Y as well as mouse BV2 cell lines treated with exogenous oligomeric Aβ. Our results demonstrated that single injection of Aβ oligomers induces long-lasting activation of microglia and astrocytes in the hippocampus. We observed also profound, early inflammatory response in the mice hippocampus, leading to the significant elevation of pro-inflammatory cytokines expression (e.g. TNF-α, IL-1β, IL-6). Moreover, Aβ oligomers elevated the formation of truncated protein p25 in mouse hippocampus and induced overactivation of Cdk5 in neuronal cells. Importantly, administration of roscovitine reduced the inflammatory processes evoked by Aβ in the hippocampus, leading to the significant decrease of cytokines level. These studies clearly show the involvement of Cdk5 in modulation of brain inflammatory response induced by Aβ and may indicate this kinase as a novel target for pharmacological intervention in AD.